ASSESSMENT OF THE ENVIRONMENTAL AND GENETIC FACTORS INFLUENCING PREVALENCE OF METABOLIC SYNDROME IN SAUDI ARABIA
Main Article Content
Keywords
#
Abstract
The risk of cardiovascular atherosclerotic diseases is increased by metabolic syndrome (MS), which is a combination of diabetes, obesity, dyslipidemia, and elevated blood pressure. Cardiovascular maladies are a prominent contributor to mortality among adult Saudi citizens, with the rise in the prevalence of multiple sclerosis compounding this trend. Metabolic syndrome is a complex disorder that arises from the interplay of genetic and environmental factors. The purpose of this article is to offer a thorough evaluation of the genetic and environmental factors that have been examined in order to explain the high incidence of MS in the Kingdom of Saudi Arabia. Furthermore, the objective of this review is to elucidate population genetic factors specific to Saudi Arabia that could potentially account for a portion of the prevalence of multiple sclerosis.
Downloads
References
1. Thomas D. Statistical Methods in Genetic Epidemiology. New York (NY): Oxford University Press; 2004. [Google Scholar] 2. Federation ID. [cited 2015 April 23];IDF Worldwide Definition of the Metabolic Syndrome. Available from: http://www.idf.org/metabolic-syndrome . [Google Scholar] 3. Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC Med. 2011;9:48. [PMC free article] [PubMed] [Google Scholar] 4. Bahijri SM, Al Raddadi RM. The importance of local criteria in the diagnosis of metabolic syndrome in Saudi Arabia. Ther Adv Endocrinol Metab. 2013;4:51–59. [PMC free article] [PubMed] [Google Scholar] 5. Al-Nozha M, Al-Khadra A, Arafah MR, Al-Maatouq MA, Khalil MZ, Khan NB, et al. Metabolic syndrome in Saudi Arabia. Saudi Med J. 2005;26:1918–1925. [PubMed] [Google Scholar] 6. Ministry of Health. [cited 2015 April 12];Survey of Health Information. 2013 Available from: http://www.moh.gov.sa/en/ministry/statistics/pages/healthinformatics.aspx . [Google Scholar] 7. Bin Horaib G, Al-Khashan HI, Mishriky AM, Selim MA, Alnowaiser N, Binsaeed AA, et al. Prevalence of obesity among military personnel in Saudi Arabia and associated risk factors. Saudi Med J. 2013;34:401–407. [PubMed] [Google Scholar] 8. Washi SA, Ageib MB. Poor diet quality and food habits are related to impaired nutritional status in 13- to 18-year-old adolescents in Jeddah. Nutr Res. 2010;30:527–534. [PubMed] [Google Scholar] 9. Al-Hazzaa HM, Abahussain NA, Al-Sobayel HI, Qahwaji DM, Musaiger AO. Physical activity, sedentary behaviors and dietary habits among Saudi adolescents relative to age, gender and region. Int J Behav Nutr Phys Act. 2011;8:140. [PMC free article] [PubMed] [Google Scholar] 10. Alkhunaizi AM, Al JH, Al SZ. Salt intake in Eastern Saudi Arabia. East Mediterr Health J. 2013;19:915–918. [PubMed] [Google Scholar] 11. Dunford E, Webster J, Woodward M, Czernichow S, Yuan WL, Jenner K, et al. The variability of reported salt levels in fast foods across six countries: opportunities for salt reduction. CMAJ. 2012;184:1023–1028. [PMC free article] [PubMed] [Google Scholar] 12. Al-Rukban MO. Obesity among Saudi male adolescents in Riyadh, Saudi Arabia. Saudi Med J. 2003;24:27–33. [PubMed] [Google Scholar] 13. AlQuaiz AM, Tayel SA. Barriers to a healthy lifestyle among patients attending primary care clinics at a university hospital in Riyadh. Ann Saudi Med. 2009;29:30–35. [PMC free article] [PubMed] [Google Scholar] 14. Al-Hazzaa H, Sulaimani R. Maximal oxygen uptake and daily physical activity in 7-to-12 year-old boys. Pediatric Exercise Science. 1993;5:357–366. [Google Scholar] 15. Al-Rafaee SA, Al-Hazzaa HM. Physical activity profile of adult males in Riyadh City. Saudi Med J. 2001;22:784–789. [PubMed] [Google Scholar] 16. Al-Hazzaa HM. Physical Activity Profiles of College Male Subjects. Journal of King Saud University. 1990:2. [Google Scholar] 17. Al-Nakeeb Y, Lyons M, Collins P, Al-Nuaim A, Al-Hazzaa H, Duncan MJ, et al. Obesity, physical activity and sedentary behavior amongst British and Saudi youth: a cross-cultural study. Int J Environ Res Public Health. 2012;9:1490–1506. [PMC free article] [PubMed] [Google Scholar] 18. Taha AZ. Self-reported knowledge and pattern of physical activity among school students in Al Khobar, Saudi Arabia. East Mediterr Health J. 2008;14:344–355. [PubMed] [Google Scholar] 19. Amin TT, Al Khoudair AS, Al Harbi MA, Al Ali AR. Leisure time physical activity in Saudi Arabia: prevalence, pattern and determining factors. Asian Pac J Cancer Prev. 2012;13:351–360. [PubMed] [Google Scholar] 20. Al-Nozha MM, Al-Hazzaa HM, Arafah MR, Al-Khadra A, Al-Mazrou YY, Al-Maatouq MA, et al. Prevalence of physical activity and inactivity among Saudis aged 30-70 years. A population-based cross-sectional study. Saudi Med J. 2007;28:559–568. [PubMed] [Google Scholar] 21. Sidawi B, Al-Hariri MT. The impact of built environment on diabetic patients: the case of Eastern Province, Kingdom of Saudi Arabia. Glob J Health Sci. 2012;4:126–138. [PMC free article] [PubMed] [Google Scholar] 22. Almajwal AM. Correlations of Physical Activity, Body Mass Index, Shift Duty, and Selected Eating Habits among Nurses in Riyadh, Saudi Arabia. Ecol Food Nutr. 2015;54:397–417. [PubMed] [Google Scholar] 23. Chang Y, Cheng Y, Yu Hsiang, Chuang LM. Molecular Genetics of Metabolic Syndrome. eLS John Wiley & Sons Online Library; 2013. [Google Scholar] 24. Al-Daghri NM, Al-Attas OS, Alkharfy KM, Khan N, Mohammed AK, Vinodson B, et al. Association of VDR-gene variants with factors related to the metabolic syndrome, type 2 diabetes and vitamin D deficiency. Gene. 2014;542:129–133. [PubMed] [Google Scholar] 25. Ntzani EE, Kavvoura FK. Genetic risk factors for type 2 diabetes: insights from the emerging genomic evidence. Curr Vasc Pharmacol. 2012;10:147–155. [PubMed] [Google Scholar] 26. Billings LK, Florez JC. The genetics of type 2 diabetes: what have we learned from GWAS? Ann N Y Acad Sci. 2010;1212:59–77. [PMC free article] [PubMed] [Google Scholar] 27. Alharbi KK, Khan IA, Munshi A, Alharbi FK, Al-Sheikh Y, Alnbaheen MS. Association of the genetic variants of insulin receptor substrate 1 (IRS-1) with type 2 diabetes mellitus in a Saudi population. Endocrine. 2014;47:472–477. [PubMed] [Google Scholar] 28. Alharbi KK, Khan IA, Al-Daghri NM, Munshi A, Sharma V, Mohammed AK, et al. ABCA1 C69T gene polymorphism and risk of type 2 diabetes mellitus in a Saudi population. Journal of Biosciences. 2013;38:893–897. [PubMed] [Google Scholar] 29. Al-Daghri NM, Alkharfy KM, Alokail MS, Alenad AM, Al-Attas OS, Mohammed AK, et al. Assessing the contribution of 38 genetic loci to the risk of type 2 diabetes in the Saudi Arabian Population. Clin Endocrinol (Oxf) 2014;80:532–537. [PubMed] [Google Scholar] 30. Bazzi MD, Nasr FA, Alanazi MS, Alamri A, Turjoman AA, Moustafa AS, et al. Association between FTO, MC4R, SLC30A8, and KCNQ1 gene variants and type 2 diabetes in Saudi population. Genet Mol Res. 2014;13:10194–10203. [PubMed] [Google Scholar] 31. Filus A, Trzmiel A, Kuliczkowska-Plaksej J, Tworowska U, Jedrzejuk D, Milewicz A, et al. Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome. Aging Male. 2008;11:134–139. [PubMed] [Google Scholar] 32. Bid HK, Konwar R, Aggarwal CG, Gautam S, Saxena M, Nayak VL, et al. Vitamin D receptor (FokI BsmI and TaqI) gene polymorphisms and type 2 diabetes mellitus: a North Indian study. Indian J Med Sci. 2009;63:187–194. [PubMed] [Google Scholar] 33. Cauchi S, El Achhab Y, Choquet H, Dina C, Krempler F, Weitgasser R, et al. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med (Ber) 2007;85:777–782. [PubMed] [Google Scholar] 34. Vimaleswaran KS, Loos RJ. Progress in the genetics of common obesity and type 2 diabetes. Expert Rev Mol Med. 2010;12:e7. [PubMed] [Google Scholar] 35. Grarup N, Andersen G, Krarup NT, Albrechtsen A, Schmitz O, Jørgensen T, et al. Association testing of novel type 2 diabetes risk alleles in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 loci with insulin release, insulin sensitivity, and obesity in a population-based sample of 4,516 glucose-tolerant middle-aged Danes. Diabetes. 2008;57:2534–2540. [PMC free article] [PubMed] [Google Scholar] 36. Ingelsson E, Langenberg C, Hivert M-F, Prokopenko I, Lyssenko V, Dupuis J, et al. Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes. 2010;59:1266–1275. [PMC free article] [PubMed] [Google Scholar] 37. Hatanaka M, Tanabe K, Yanai A, Ohta Y, Kondo M, Akiyama M, et al. Wolfram syndrome 1 gene (WFS1) product localizes to secretory granules and determines granule acidification in pancreatic beta-cells. Hum Mol Genet. 2011;20:1274–1284. [PubMed] [Google Scholar] 38. Wang H, Antinozzi PA, Hagenfeldt KA, Maechler P, Wollheim CB. Molecular targets of a human HNF1 alpha mutation responsible for pancreatic beta-cell dysfunction. EMBO J. 2000;19:4257–4264. [PMC free article] [PubMed] [Google Scholar] 39. Xu H, Dembski M, Yang Q, Yang D, Moriarty A, Tayber O, et al. Dual specificity mitogen-activated protein (MAP) kinase phosphatase-4 plays a potential role in insulin resistance. J Biol Chem. 2003;278:30187–30192. [PubMed] [Google Scholar] 40. Brunham LR, Kruit JK, Pape TD, Timmins JM, Reuwer AQ, Vasanji Z, et al. Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment. Nat Med. 2007;13:340–347. [PubMed] [Google Scholar] 41. Grarup N, Rose CS, Andersson EA, Andersen G, Nielsen AL, Albrechtsen A, et al. Studies of association of variants near the HHEX CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies. Diabetes. 2007;56:3105–3111. [PubMed] [Google Scholar] 42. Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet. 1996;12:17–23. [PubMed] [Google Scholar] 43. Yamagata K, Senokuchi T, Lu M, Takemoto M, Fazlul Karim M, Go C, et al. Voltage-gated K(+) channel KCNQ1 regulates insulin secretion in MIN6 beta-cell line. Biochem Biophys Res Commun. 2011;407:620–625. [PubMed] [Google Scholar] 44. Nelson DL, Cox MM. Biosignaling. In: Lehninger Principles of Biochemistry. 2nd ed. New York (NY): WH Freeman & Company; 2008. [Google Scholar] 45. Ehret GB. Genome-Wide Association Studies: Contribution of Genomics to Understanding Blood Pressure and Essential Hypertension. Curr Hypertens Rep. 2010;12:17–25. [PMC free article] [PubMed] [Google Scholar] 46. Ji LD, Zhang LN, Xu J. Genome-wide association studies of hypertension: achievements, difficulties and strategies. World J Hypertens. 2011;1:10–14. [Google Scholar] 47. Alghasham A, Settin AA, Ali A, Dowaidar M, Ismail H. Association of MTHFR C677T and A1298C gene polymorphisms with hypertension. Int J Health Sci (Qassim) 2012;6:3–11. [PMC free article] [PubMed] [Google Scholar] 48. Ali A, Alghasham A, Ismail H, Dowaidar M, Settin A. ACE I/D and eNOS E298D gene polymorphisms in Saudi subjects with hypertension. J Renin Angiotensin Aldosterone Syst. 2013;14:348–353. [PubMed] [Google Scholar] 49. Alghasham A, Ali A, Ismail H, Dowaidar M, Settin AA. CYP2J2-50 G/T and ADRB2 G46A gene polymorphisms in Saudi subjects with hypertension. Genet Test Mol Biomarkers. 2012;16:1027–1031. [PubMed] [Google Scholar] 50. Srivastava K, Sundriyal R, Meena PC, Bhatia J, Narang R, Saluja D. Association of angiotensin converting enzyme (insertion/deletion) gene polymorphism with essential hypertension in northern Indian subjects. Genet Test Mol Biomarkers. 2012;16:174–177. [PubMed] [Google Scholar] 51. Xi B, Shen Y, Zhao X, Chandak GR, Cheng H, Hou D, et al. Association of common variants in/near six genes (ATP2B1, CSK, MTHFR, CYP17A1, STK39 and FGF5) with blood pressure/hypertension risk in Chinese children. J Hum Hypertens. 2014;28:32–36. [PubMed] [Google Scholar] 52. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111–113. [PubMed] [Google Scholar] 53. Stehouwer CD, van Guldener C. Does homocysteine cause hypertension? Clin Chem Lab Med. 2003;41:1408–1411. [PubMed] [Google Scholar] 54. Baudin B. New aspects on angiotensin-converting enzyme: from gene to disease. Clin Chem Lab Med. 2002;40:256–265. [PubMed] [Google Scholar] 55. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev. 2002;82:131–185. [PubMed] [Google Scholar] 56. Alharbi KK, Richardson TG, Khan IA, Syed R, Mohammed AK, Boustred CR, et al. Influence of adiposity-related genetic markers in a population of Saudi Arabians where other variables influencing obesity may be reduced. Dis Markers. 2014;2014:758232. [PMC free article] [PubMed] [Google Scholar] 57. Al-Daghri NM, Alkharfy KM, Al-Attas OS, Krishnaswamy S, Mohammed AK, Albagha OM, et al. Association between type 2 diabetes mellitus-related SNP variants and obesity traits in a Saudi population. Mol Biol Rep. 2014;41:1731–1740. [PubMed] [Google Scholar] 58. Daghestani MH, Warsy A, Al-Odaib AN, Eldali A, Al-Eisa NA, Omer SA, et al. Arginine 16 Glycine Polymorphism in β2-Adrenergic Receptor Gene is Associated with Obesity, Hyperlipidemia, Hyperleptinemia and Insulin Resistance in Saudis. Int J Endocrinol. 2012;2012:945608. [PMC free article] [PubMed] [Google Scholar] 59. Dell’Angelica EC, Ohno H, Ooi CE, Rabinovich E, Roche KW, Bonifacino JS. AP-3: an adaptor-like protein complex with ubiquitous expression. EMBO J. 1997;16:917–928. [PMC free article] [PubMed] [Google Scholar] 60. Kooner JS, Saleheen D, Sim X, Sehmi J, Zhang W, Frossard P, et al. Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet. 2011;43:984–989. [PMC free article] [PubMed] [Google Scholar] 61. McCaffery JM, Papandonatos GD, Peter I, Huggins GS, Raynor HA, Delahanty LM, et al. Obesity susceptibility loci and dietary intake in the Look AHEAD Trial. Am J Clin Nutr. 2012;95:1477–1486. [PMC free article] [PubMed] [Google Scholar] 62. Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, Hu T, et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet. 2008;40:638–645. [PMC free article] [PubMed] [Google Scholar] 63. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316:889–894. [PMC free article] [PubMed] [Google Scholar] 64. Boes E, Coassin S, Kollerits B, Heid IM, Kronenberg F. Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review. Exp Gerontol. 2009;44:136–160. [PMC free article] [PubMed] [Google Scholar] 65. Falconer DS, Mackay TFC. Introduction to quantitative genetics. San Francisco (SF): Benjamin Cummings; 1996. [Google Scholar] 66. Neel JV. Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”? American Journal of Human Genetics. 1962;14:353–362. [PMC free article] [PubMed] [Google Scholar] 67. el-Hazmi MA, al-Swailem AR, Warsy AS, al-Swailem AM, Sulaimani R, al-Meshari AA. Consanguinity among the Saudi Arabian population. J Med Genet. 1995;32:623–626. [PMC free article] [PubMed] [Google Scholar] 68. El Mouzan MI, Al Salloum AA, Al Herbish AS, Qurachi MM, Al Omar AA. Consanguinity and major genetic disorders in Saudi children: a community-based cross-sectional study. Ann Saudi Med. 2008;28:169–173. [PMC free article] [PubMed] [Google Scholar] 69. El-Mouzan MI, Al-Salloum AA, Al-Herbish AS, Qurachi MM, Al-Omar AA. Regional variations in the prevalence of consanguinity in Saudi Arabia. Saudi Med J. 2007;28:1881–1884. [PubMed] [Google Scholar] 70. Bener A, Zirie M, Al-Rikabi A. Genetics, obesity, and environmental risk factors associated with type 2 diabetes. Croat Med J. 2005;46:302–307. [PubMed] [Google Scholar] 71. Anokute CC. Suspected synergism between consanguinity and familial aggregation in type 2 diabetes mellitus in Saudi Arabia. J R Soc Health. 1992;112:167–169. [PubMed] [Google Scholar] 72. Gosadi IM, Goyder EC, Teare MD. Investigating the potential effect of consanguinity on type 2 diabetes susceptibility in Saudi population. Hum Hered. 2014;77:197–206. [PubMed] [Google Scholar]
Issue
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.